{"id":"https://openalex.org/W7204088419","doi":"https://doi.org/10.1021/acsmedchemlett.6c00360","title":"Discovery of Novel Bicyclic Pyrazole Amides as Potent Neuronal KV7 Potassium Channel Openers with Strong Preclinical Antiseizure Activity","display_name":"Discovery of Novel Bicyclic Pyrazole Amides as Potent Neuronal KV7 Potassium Channel Openers with Strong Preclinical Antiseizure Activity","publication_year":2026,"publication_date":"2026-08-22","ids":{"openalex":"https://openalex.org/W7204088419","doi":"https://doi.org/10.1021/acsmedchemlett.6c00360","pmid":"https://pubmed.ncbi.nlm.nih.gov/42741311","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13573258"},"language":"en","primary_location":{"id":"doi:10.1021/acsmedchemlett.6c00360","doi":"https://doi.org/10.1021/acsmedchemlett.6c00360","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acsmedchemlett.6c00360","pdf_url":null,"source":{"id":"https://openalex.org/S191852912","display_name":"ACS Medicinal Chemistry Letters","issn_l":"1948-5875","issn":["1948-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13573258/pdf/ml6c00360.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071662621","display_name":"Shaoyi Sun","orcid":"https://orcid.org/0000-0002-2946-9510","observed_orcids":["https://orcid.org/0000-0002-2946-9510"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Shaoyi Sun","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":"https://orcid.org/0000-0002-2946-9510","affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147956225","display_name":"Qi Jia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qi Jia","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013583244","display_name":"Girish R. Bankar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Girish Bankar","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044987178","display_name":"Kristen Burford","orcid":"https://orcid.org/0009-0007-4067-7672","observed_orcids":["https://orcid.org/0009-0007-4067-7672"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristen N. Burford","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":"https://orcid.org/0009-0007-4067-7672","affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092601948","display_name":"Jessica Christabel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jessica Christabel","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114267481","display_name":"Helen A. Clement","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helen A. Clement","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032069914","display_name":"Gina de Boer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gina de Boer","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148033243","display_name":"Zirui Feng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zirui Feng","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016526305","display_name":"Chido M. Hambira","orcid":"https://orcid.org/0000-0002-8119-9538","observed_orcids":["https://orcid.org/0000-0002-8119-9538"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chido M. Hambira","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":"https://orcid.org/0000-0002-8119-9538","affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147973253","display_name":"Stephen K. Jackson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen K. Jackson","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035901476","display_name":"Kuldip Khakh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kuldip Khakh","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069524654","display_name":"Rainbow Kwan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rainbow Kwan","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085577202","display_name":"S C Lee","orcid":"https://orcid.org/0009-0003-6198-7275","observed_orcids":["https://orcid.org/0009-0003-6198-7275"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephanie Lee","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103237792","display_name":"Jenny Li","orcid":"https://orcid.org/0000-0003-4119-5310","observed_orcids":["https://orcid.org/0000-0003-4119-5310"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jenny Li","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043353596","display_name":"Andrea Lindgren","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrea Lindgren","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111720475","display_name":"Janette Mezeyova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Janette Mezeyova","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148030318","display_name":"Juliette Sabbatini","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juliette Sabbatini","raw_affiliation_strings":["X-Chem Canada , 4800 Rue Levy , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"X-Chem Canada , 4800 Rue Levy , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047097120","display_name":"Art Urrutia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Art Urrutia","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148030649","display_name":"Paul Charifson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Charifson","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103233828","display_name":"Michael P. Clark","orcid":"https://orcid.org/0000-0003-1628-1671","observed_orcids":["https://orcid.org/0000-0003-1628-1671"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael P. Clark","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021036086","display_name":"Steven S. Wesolowski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven S. Wesolowski","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009838042","display_name":"James P. Johnson","orcid":"https://orcid.org/0000-0002-5762-5138","observed_orcids":["https://orcid.org/0000-0002-5762-5138"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James P. Johnson","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113985909","display_name":"James R. Empfield","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James R. Empfield","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050077581","display_name":"Christoph M. Dehnhardt","orcid":"https://orcid.org/0000-0001-5213-6354","observed_orcids":["https://orcid.org/0000-0001-5213-6354"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christoph M. Dehnhardt","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":"https://orcid.org/0000-0001-5213-6354","affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043846225","display_name":"Richard A. Dean","orcid":"https://orcid.org/0000-0003-0000-5357","observed_orcids":["https://orcid.org/0000-0003-0000-5357"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Richard Dean","raw_affiliation_strings":["Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xenon Pharmaceuticals, Inc. , 3650 Gilmore Way , , ,","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5043846225","https://openalex.org/A5071662621"],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.51670819,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":"9","first_page":"2027","last_page":"2037"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.8140000104904175,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.8140000104904175,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.1542000025510788,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.018400000408291817,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kcnq2","display_name":"KCNQ2","score":0.8939999938011169},{"id":"https://openalex.org/keywords/kcnq3","display_name":"KCNQ3","score":1.0},{"id":"https://openalex.org/keywords/antiseizure-activity","display_name":"antiseizure activity","score":0.8669999837875366},{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.6420000195503235},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8619999885559082},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8029999732971191},{"id":"https://openalex.org/keywords/maximal-electroshock-seizures","display_name":"maximal electroshock seizures","score":0.7699999809265137}],"concepts":[{"id":"https://openalex.org/C83743174","wikidata":"https://www.wikidata.org/wiki/Q423778","display_name":"Potassium channel","level":2,"score":0.7196000218391418},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6384000182151794},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6301000118255615},{"id":"https://openalex.org/C2777194220","wikidata":"https://www.wikidata.org/wiki/Q1722307","display_name":"Potassium channel opener","level":3,"score":0.5909000039100647},{"id":"https://openalex.org/C2778457506","wikidata":"https://www.wikidata.org/wiki/Q7234689","display_name":"Potassium channel blocker","level":3,"score":0.44510000944137573},{"id":"https://openalex.org/C517785266","wikidata":"https://www.wikidata.org/wiki/Q703","display_name":"Potassium","level":2,"score":0.4424999952316284},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4332999885082245},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.4074000120162964},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.39910000562667847},{"id":"https://openalex.org/C2777682936","wikidata":"https://www.wikidata.org/wiki/Q408908","display_name":"Pyrazole","level":2,"score":0.3718000054359436},{"id":"https://openalex.org/C24961977","wikidata":"https://www.wikidata.org/wiki/Q225972","display_name":"Bicyclic molecule","level":2,"score":0.33730000257492065},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.31769999861717224},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.31209999322891235},{"id":"https://openalex.org/C2993436365","wikidata":"https://www.wikidata.org/wiki/Q925958","display_name":"Locomotor activity","level":2,"score":0.30399999022483826},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.2718999981880188},{"id":"https://openalex.org/C164126121","wikidata":"https://www.wikidata.org/wiki/Q766383","display_name":"Quantitative structure\u2013activity relationship","level":2,"score":0.2700999975204468},{"id":"https://openalex.org/C2778460930","wikidata":"https://www.wikidata.org/wiki/Q7447053","display_name":"Seizure threshold","level":4,"score":0.2651999890804291},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.257999986410141},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.2513999938964844}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1021/acsmedchemlett.6c00360","doi":"https://doi.org/10.1021/acsmedchemlett.6c00360","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acsmedchemlett.6c00360","pdf_url":null,"source":{"id":"https://openalex.org/S191852912","display_name":"ACS Medicinal Chemistry Letters","issn_l":"1948-5875","issn":["1948-5875"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13573258","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13573258/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13573258/pdf/ml6c00360.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Med Chem Lett","raw_type":"Text"},{"id":"pmid:42741311","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42741311","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:13573258","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13573258/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13573258/pdf/ml6c00360.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ACS Med Chem Lett","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204088419.pdf","grobid_xml":"https://content.openalex.org/works/W7204088419.grobid-xml"},"referenced_works_count":41,"referenced_works":["https://openalex.org/W66191222","https://openalex.org/W1664352025","https://openalex.org/W1736719008","https://openalex.org/W1985136179","https://openalex.org/W1994497897","https://openalex.org/W1997537641","https://openalex.org/W2013500670","https://openalex.org/W2021764598","https://openalex.org/W2026064865","https://openalex.org/W2029601828","https://openalex.org/W2030440002","https://openalex.org/W2040066247","https://openalex.org/W2062463079","https://openalex.org/W2070032514","https://openalex.org/W2071335594","https://openalex.org/W2074274985","https://openalex.org/W2112272723","https://openalex.org/W2118970449","https://openalex.org/W2135893137","https://openalex.org/W2162891493","https://openalex.org/W2408529313","https://openalex.org/W2737459506","https://openalex.org/W2785609333","https://openalex.org/W2912348437","https://openalex.org/W2917680118","https://openalex.org/W2968038169","https://openalex.org/W2972850585","https://openalex.org/W3119057473","https://openalex.org/W3133877026","https://openalex.org/W3158803573","https://openalex.org/W3201079407","https://openalex.org/W4292004335","https://openalex.org/W4403348575","https://openalex.org/W4406801261","https://openalex.org/W4408244205","https://openalex.org/W4409247590","https://openalex.org/W4410775242","https://openalex.org/W4412488772","https://openalex.org/W4412578891","https://openalex.org/W4413112663","https://openalex.org/W7130520754"],"related_works":["https://openalex.org/W2162837382","https://openalex.org/W4413112663","https://openalex.org/W2893746145","https://openalex.org/W7097242242","https://openalex.org/W2094937027","https://openalex.org/W2944262283","https://openalex.org/W4408808831","https://openalex.org/W2913065090","https://openalex.org/W1856660863","https://openalex.org/W2912072041"],"abstract_inverted_index":{"Abstract":[0],"There":[1],"has":[2],"been":[3],"considerable":[4],"interest":[5],"in":[6,31,74,92,99],"developing":[7],"openers":[8],"of":[9,39,42,60,68,77],"neuronal":[10,43,84],"KV7":[11,44,85],"potassium":[12,45],"channels,":[13],"particularly":[14],"KV7.2":[15],"(KCNQ2)":[16],"and":[17,23,53,81,95],"KV7.3":[18],"(KCNQ3),":[19],"as":[20],"both":[21],"genetic":[22],"clinical":[24],"evidence":[25],"strongly":[26],"support":[27],"their":[28],"therapeutic":[29],"potential":[30],"seizure":[32,104],"disorders.":[33],"Herein,":[34],"we":[35],"describe":[36],"the":[37,69,75],"discovery":[38,76],"a":[40,79],"series":[41],"channel":[46],"openers,":[47],"optimized":[48],"primarily":[49],"via":[50],"conformational":[51],"rigidification":[52],"carbon":[54],"to":[55],"oxygen":[56],"replacement.":[57],"The":[58],"combination":[59],"these":[61],"structural":[62],"modifications,":[63],"together":[64],"with":[65],"careful":[66],"investigation":[67],"structure\u2013activity":[70],"relationship":[71],"(SAR),":[72],"culminated":[73],"S-35,":[78],"potent":[80],"metabolically":[82],"stable":[83],"opener":[86],"that":[87],"demonstrated":[88],"favorable":[89],"pharmacokinetics":[90],"(PK)":[91],"preclinical":[93],"species":[94],"robust":[96],"antiseizure":[97],"efficacy":[98],"rodent":[100],"alternating-current":[101],"maximal":[102],"electroshock":[103],"(AC-MES)":[105],"assays.":[106]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-08-25T00:00:00"}